The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension

Published:2021-01 Issue: Volume:534 Page:795-801
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Yamamura Aya^ORCID,Nayeem Md Junayed,Sato Motohiko

Funder

Japan Society for the Promotion of Science

Grants-in-Aid from the Takeda Science Foundation

Toyoaki Scholarship Foundation

24th General Assembly of the Japanese Association of Medical Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. Management of pulmonary arterial hypertension;McLaughlin;J. Am. Coll. Cardiol.,2015

2. Cellular and molecular basis of pulmonary arterial hypertension;Morrell;J. Am. Coll. Cardiol.,2009

3. Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017);Fukuda;Circ. J.,2019

4. RhoA/Rho-kinase in the cardiovascular system;Shimokawa;Circ. Res.,2016

5. The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease;Hartmann;Front. Pharmacol.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction;American Journal of Respiratory Cell and Molecular Biology;2024-07

2. Targeting MAD2B as a strategy for ischemic stroke therapy;Journal of Advanced Research;2024-07

3. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension;European Journal of Pharmacology;2024-06

4. Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation—a systematic review;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-15

5. Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension;Expert Opinion on Investigational Drugs;2023-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3